Pauline Vaflard (P Vaflard)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Tyrosine Kinase

Epstein Barr Virus

Patient Reported

Top Venues

British journal of clinical pharmacology

Pilot and feasibility studies

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Alexandre Acramel, Sandy Blondeel-Gomes, Mathilde Dupré, Ornella Tangila Kayembe, Aude Rochereau, Laurence Escalup, Romain-Pacôme Desmaris, Nathalie Jourdan, Adeline Cordary, Pauline Vaflard, Paul-Henri Cottu, Audrey Bellesoeur
Advanced prescription of injectable anticancer drugs: Safety assessment in a European Comprehensive Cancer Centre using the risk matrix approach. British journal of clinical pharmacology (2024)
Aude Rault, Sylvie Dolbeault, Johanna Terrasson, Carole Bouleuc, Paul-Henri Cottu, Sophie Piperno-Neumann, Manuel J Rodrigues, Pauline Vaflard, Anne Brédart
Facilitating patient-oncologist communication in advanced treatment-resistant cancer: development and feasibility testing of a question prompt list. Pilot and feasibility studies 10 (1) (2024)
Aude Rault, Sylvie Dolbeault, Johanna Terrasson, Carole Bouleuc, Paul-Henri Cottu, Sophie Piperno-Neumann, Manuel J Rodrigues, Pauline Vaflard, Anne Brédart
Facilitating patient-oncologist communication in advanced treatment-resistant cancer: development and feasibility testing of a question prompt list. Pilot and feasibility studies 10 (1) (2024)
Alexandre Acramel, Sandy Blondeel-Gomes, Mathilde Dupré, Ornella Tangila Kayembe, Aude Rochereau, Laurence Escalup, Romain-Pacôme Desmaris, Nathalie Jourdan, Adeline Cordary, Pauline Vaflard, Paul-Henri Cottu, Audrey Bellesoeur
Advanced prescription of injectable anticancer drugs: Safety assessment in a European Comprehensive Cancer Centre using the risk matrix approach. British journal of clinical pharmacology 90 (5) (2024)
Sarah Watson, Joanna Cyrta, Marine Lefevre, Julien Masliah Planchon, Christophe Louvet, Vincent Servois, Pauline Vaflard, François Clément Bidard, Ivan Bieche, Emilie Soularue
Hyperprogressive Disease After Pembrolizumab Treatment in Advanced Epstein-Barr Virus-Associated Gastric Adenocarcinoma With ERBB2 Amplification. JCO precision oncology 5 (2022)